Table 3.
Notification of adverse events, evidence level > 2,2000–2006
| AR/1,000 APC | AR/1,000 PP | |
|---|---|---|
| FNHTR | 1,617 | 0,883 |
| Allergy | 5,001 | 1,595 |
| Alloimmunization | 0,292 | 0,864 |
| Unknown | 0,797 | 0,351 |
| Immunologie imcompatibility | 0,391 | 0,370 |
| Transfusion inefficiency | 0,244 | 0,062 |
| TACO | 0,062 | 0,024 |
| Virus infection | 0,002 | 0,000 |
| Other immediate AR | 0,121 | 0,009 |
| TTBI | 0,037 | 0,033 |
| TRALI | 0,033 | 0,005 |
| Other delayed AR | 0,015 |
0,000 |
| A11AR | 8,612 | 4,211 |
| Death | 0,018 | 0,009 |
FNHTR = Febrile nonhemolytic transfusion reaction; TACO = transfusion-associated circulatory; TRALI = transfusion-related acute lung injury; TTBI = transfusion-transmitted bacterial infections.